Our co-founder, Dr. Satabhisa Mukhopadhyay, and Dr. Rajendra Singh, co-founder of PathPresenter, were recently interviewed by Drug Discovery & Development about how our recent partnership could improve the diagnostic accuracy of breast tumor profiling and how drug developers may benefit from our alliance in oncology clinical trials.
“For these workflow solutions to be effective, you need good AI models running in the background,” said Dr. Rajendra Singh, co-founder of PathPresenter. “And one of the best companies on the planet right now producing AI models is 4D Path.”